Evidence map›Paper›PMID 36895558›Full record

ReviewFrontiers in immunology2023

Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues.

Diane Giovannini, Aude Belbezier, Athan Baillet, Laurence Bouillet, Mitsuhiro Kawano, Chantal Dumestre-Perard, Giovanna Clavarino, Johan Noble, Jacques-Olivier Pers, Nathalie Sturm and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Diane GiovanniniDepartment of Pathology, Grenoble University Hospital, Grenoble, France.
Aude BelbezierTranslational Research in Autoimmunity and Inflammation Group (TRAIG), Translational Innovation in Medicine and Complexity (TIMC), University Grenoble-Alpes, CNRS Unité mixte de recherche (UMR) 5525, Grenoble, France.
Athan BailletTranslational Research in Autoimmunity and Inflammation Group (TRAIG), Translational Innovation in Medicine and Complexity (TIMC), University Grenoble-Alpes, CNRS Unité mixte de recherche (UMR) 5525, Grenoble, France.
Laurence BouilletTranslational Research in Autoimmunity and Inflammation Group (TRAIG), Translational Innovation in Medicine and Complexity (TIMC), University Grenoble-Alpes, CNRS Unité mixte de recherche (UMR) 5525, Grenoble, France.
Mitsuhiro KawanoDepartment of Rheumatology, Kanazawa University Hospital, Kanazawa, Japan.
Chantal Dumestre-PerardImmunology Laboratory, Grenoble University Hospital, Grenoble, France.
Giovanna ClavarinoImmunology Laboratory, Grenoble University Hospital, Grenoble, France.
Johan NobleDepartment of Nephrology, Grenoble University Hospital, Grenoble, France.
Jacques-Olivier PersB Lymphocytes, Autoimmunity and Immunotherapies, Brest University, INSERM, UMR1227, Brest, France.
Nathalie SturmDepartment of Pathology, Grenoble University Hospital, Grenoble, France.
Bertrand HuardTranslational Research in Autoimmunity and Inflammation Group (TRAIG), Translational Innovation in Medicine and Complexity (TIMC), University Grenoble-Alpes, CNRS Unité mixte de recherche (UMR) 5525, Grenoble, France.
Université Grenoble Alpes · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Régional Universitaire de Brest · FRCentre National de la Recherche Scientifique · FRKanazawa University Hospital · JPTranslational Innovation in Medicine and Complexity · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The humoral response is frequently dysfunctioning in autoimmunity with a frequent rise in total serum immunoglobulins, among which are found autoantibodies that may be pathogenic by themselves and/or propagate the inflammatory reaction. The infiltration of autoimmune tissues by antibody-secreting cells (ASCs) constitutes another dysfunction. The known high dependency of ASCs on the microenvironment to survive combined to the high diversity of infiltrated tissues implies that ASCs must adapt. Some tissues even within a single clinical autoimmune entity are devoid of infiltration. The latter means that either the tissue is not permissive or ASCs fail to adapt. The origin of infiltrated ASCs is also variable. Indeed, ASCs may be commonly generated in the secondary lymphoid organ draining the autoimmune tissue, and home at the inflammation site under the guidance of specific chemokines. Alternatively, ASCs may be generated locally, when ectopic germinal centers are formed in the autoimmune tissue. Alloimmune tissues with the example of kidney transplantation will also be discussed own to their high similarity with autoimmune tissues. It should also be noted that antibody production is not the only function of ASCs, since cells with regulatory functions have also been described. This article will review all the phenotypic variations indicative of tissue adaptation described so for at the level of ASC-infiltrating auto/alloimmune tissues. The aim is to potentially define tissue-specific molecular targets in ASCs to improve the specificity of future autoimmune treatments.

Indexed as

Antibody-Producing CellsAutoantibodiesAntibody FormationAutoimmunityChemokinesAutoantibodiesChemokinesantibodiesautoimmunityplasma cellstissuestreatment

Identifiers

PMID36895558
PMCPMC9989216
OpenAlexW4321459065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.